Your browser doesn't support javascript.
loading
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections.
Selva, Kevin J; Ramanathan, Pradhipa; Haycroft, Ebene R; Reynaldi, Arnold; Cromer, Deborah; Tan, Chee Wah; Wang, Lin-Fa; Wines, Bruce D; Hogarth, P Mark; Downie, Laura E; Davis, Samantha K; Purcell, Ruth A; Kent, Helen E; Juno, Jennifer A; Wheatley, Adam K; Davenport, Miles P; Kent, Stephen J; Chung, Amy W.
Affiliation
  • Selva KJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Ramanathan P; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Haycroft ER; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Reynaldi A; Kirby Institute, University of New South Wales, Kensington, New South Wales, Australia.
  • Cromer D; Kirby Institute, University of New South Wales, Kensington, New South Wales, Australia.
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Wang LF; Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Wines BD; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Hogarth PM; Singhealth Duke-NUS Global Health Institute, Singapore.
  • Downie LE; Immune Therapies Laboratory, Burnet Institute, Melbourne, Victoria, Australia.
  • Davis SK; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Purcell RA; Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.
  • Kent HE; Immune Therapies Laboratory, Burnet Institute, Melbourne, Victoria, Australia.
  • Juno JA; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Wheatley AK; Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.
  • Davenport MP; Department of Optometry and Vision Sciences, University of Melbourne, Carlton, Victoria, Australia.
  • Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
JCI Insight ; 8(18)2023 09 22.
Article in En | MEDLINE | ID: mdl-37737263
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: JCI Insight Year: 2023 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: JCI Insight Year: 2023 Document type: Article Affiliation country: Australia